According to published data, pre-operative treatment with oral doxycycline (200 mg per day) for two weeks led to a substantial reduction in CD44+ CSC number, ranging from 17.65% to 66.67%, in tumor samples from eight out of nine breast cancer patients (p-value < 0.005) [47]. The gene discussed is CD44; the disease is breast carcinoma.